| Name | Title | Contact Details |
|---|
Arise Health Plan is a De Pere, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The University of Vermont Medical Center is part of a six-hospital network serving patients and their families in Vermont and northern New York. We`re not just caregivers and staff - we`re your friends and neighbors, offering expertise, kind words and compassionate care when and where you need them. We are dedicated to providing you with the best medical care possible. The University of Vermont Medical Center, along with the Robert Larner M.D. College of Medicine The University of Vermont and College of Nursing and Health Sciences, is one of 138 academic medical centers in the country. Through The University of Vermont Health Network and collaborative relationships throughout Vermont and northern New York, we are able to provide the highest quality care, informed by academic research, to patients throughout our region. The UVM Medical Center, along with its three founding organizations, The University of Vermont College of Medicine and College of Nursing and Health Sciences, share a rich history dating back to the 1800s. The UVM Medical Center is committed to the development of an Integrated Delivery System which provides high value health care to the communities we serve and enhances our academic mission. Our mission is to improve the health of the people in the communities we serve by integrating patient care, education, and research in a caring environment.
Angela Hospice is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Institute for Work and Health is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.